Picomole Student Intern: Allison Henderson
Allison Henderson is a 3rd year public relations student at Mount Saint Vincent University. Being the first communications student on our team, her goal was to implement a communications strategy and expand on some of the existing public relations activities the Picomole team had already begun.
CTV News Article: N.B. team develops breakthrough innovative screening tool for lung cancer
Picomole CEO, Stephen Graham and UNB biomedical engineering student Robyn Larracy sat down with CTV News to discuss a Machine Learning Project to detect lung cancer using Picomole Technology.
Picomole Student Employee: Alex Chiasson
Alex Chiasson is a 4th year student at the Université du Moncton who is majoring in Physics while working part-time at Picomole. Alex is currently helping our team by monitoring our spectrometer during night shifts and weekends.
Picomole Applies Artificial Intelligence to the Detection of Lung Cancer
Picomole is the first breath analytics company to use artificial intelligence to detect lung cancer. We are excited to announce a partnership with the University of New Brunswick (UNB), with funding from Mitacs and the New Brunswick Innovation Foundation’s (NBIF), Innovation Voucher Fund to apply machine learning to raw spectral data generated by the Picomole breath analytics technology, in order to identify features found in the breath that are indicative of the presence of lung cancer.
UCI Collaborates with Picomole to Detect Early-Stage Lung Cancer in Breath
Picomole is excited to announce a new research partnership with the University of California, Irvine (UCI). The partnership is focused on a research project to detect the presence of early-stage lung cancer in breath.
Picomole Spectrometer Gaining Speed Fuelled by IRAP
Picomole’s innovative infrared absorption technology combined with machine learning algorithms allows for the processing of breath samples to provide insights into a patient’s health. It is especially promising for the monitoring of slowly progressing diseases such as cancer, respiratory diseases and neurological disorders.
Our Team is Growing
Picomole is excited to announce funding approved from the National Research Council of Canada – Industrial Research Assistance Program (NRC IRAP) under their Youth Employment Program. This funding has allowed our team at Picomole to hire an engineer and lab technician to support our engineering team working in the Moncton lab on our breath analytics technology.
Picomole CEO Participates in Canadian Technology Accelerator Program
The Canadian Trade Commissioner Service (TCS) is an organization that bridges the gap between Canadian and foreign companies. The TCS has been helping Canadian organizations in the global market for over 120 years and funds the Canadian Technology Accelerator (CTA), a service that is specific to tech companies.
Picomole Student Interns: Ousman Beebeejaun and Melissa & Melanie Renn
Picomole is proud of our partnerships with post-secondary academic institutions who provide the opportunity to hire a wealth of emerging talent for student work experiences. Student interns are a great addition to the Picomole team, we benefit from their eagerness to work, learn and we build our pipeline for future permanent hires.
Ethics Approval for Picomole Lung Cancer Study in Boston
Picomole is excited to announce a new research project in Boston to detect the presence of lung cancer in breath.
Researchers will collect samples using Picomole breath sampling technology, samples will be processed and analyzed in the Picomole laboratory to detect the presence of lung cancer identified through the analysis of Volatile Organic Compounds found in the breath.
NB-IRDT to analyze economics of Picomole lung cancer screening tool
Picomole has partnered with The New Brunswick Institute for Research, Data and Training (NB-IRDT) at UNB. This project will leverage the expertise and research capability of Picomole and its partners to undertake an economic evaluation of the Picomole lung cancer screening tool.
Picomole Abstract Published in International Conference
The results of an exciting clinical research study that could help lead to enhancements in the way people are screened for lung cancer have been published as part of a major international conference. Representatives of Picomole Inc., in partnership with Horizon Health Network, recently completed a detailed multi-year study of nearly 200 breath samples collected from lung cancer patients, in addition to healthy subjects.
Branding of Picomole Breath Sampler
Picomole is proud to be working with U-S based marketing firm specializing in life sciences, High Lantern Group, to brand our breath sampling device in anticipation of its commercial launch in early 2021. The project is generously funded by LearnSphere through the Commercialization Consulting and Mentoring (CCM) Program. This project marks the first step in the commercialization of the Picomole Breath Sampler.
Picomole and UNB Researcher Partner on Algorithm to Detect Lung Cancer
Earlier this week, Robyn Larracy BSc, presented her research on the identification of lung cancer biomarkers at the Digital Breath Biopsy Conference. Ms. Larracy is completing her master's degree in biomedical engineering. Her master's thesis focuses on the analysis of data generated from Picomole’s Cavity Ring Down Spectroscopy (CRDS) technology.
Picomole Resumes Sample Collection and Introduces Second Generation Spectrometer
Picomole Inc. is excited to announce that sample collection has commenced again, with the implementation of new COVID-19 protocols. Samples from Horizon Health Network have begun to be Processed at Picomole's laboratory in Moncton, New Brunswick. Picomole is also introducing its second generation analyzer, which allows for quicker and more accurate processing of breath samples.
Picomole Announces Peter Savas as Newest Member of it's Board of Directors
Picomole is excited to add Mr. Savas to its Board. Mr. Savas has extensive experience in the healthcare and life sciences industries, and will bring a wealth of knowledge and experience to Picomole.
Invest in Canada features Picomole as an innovator in the Atlantic Canada medtech industry
Picomole Inc. is honoured to be included in Invest In Canada's Medtech companies in Atlantic Canada to keep an eye on. Picomole continues to strive towards its goal of non-invasive screening method for diseases such as lung cancer. Picomole's breath analytics approach to disease screening will change the way disease is detected for years to come!
Picomole reaches agreement with CRID for regulatory funding
Picomole is pleased to announce that it has reached an agreement with the Centre de Recherche et Innovation Dieppe Inc. (CRID) which will aid Picomole in the rigorous process of regulatory validation for the Picomole Breath Sampler with the FDA and Health Canada
Picomole receives ethics approval from Horizon for breast cancer proof of concept study
Picomole Inc. is pleased to announce it has received ethics approvals in collaboration with the Horizon Health Network (Horizon), which will allow the Moncton-based company to move ahead with the development of an exciting breast cancer proof of concept study.
Picomole Resumes Sample Collection and Introduces Second Generation Spectrometer
Representatives of Picomole Inc., in partnership with Horizon Health Network and with the help of the New Brunswick Health Research Foundation, recently completed a detailed multi-year study of nearly 200 breath samples collected from lung cancer patients, in addition to healthy subjects.
Minister of Health Presents Picomole with Funding Award
Minister of Health, Ginette Petitpas Taylor, presents Picomole funding award
The Honourable Ginette Petitpas Taylor, Minister of Health and Member of Parliament for Moncton-Riverview-Dieppe, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for ACOA announced today that the Government of Canada is providing a total contribution of $818,000 to Picomole through the Atlantic Canada Opportunities Agency (ACOA) and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
BioNova Announces Picomole as the Winner of the Eighth Annual BioInnovation Challenge (BIC) at BioPort 2018
Today Picomole from Moncton, New Brunswick was named the winner of BioNova’s eighth annual BioInnovation Challenge (BIC) business pitch competition at BioPort 2018.
Dr. Stephen Douglas Graham Appointed CEO of Picomole Inc.
Picomole is excited to announce that Dr. Stephen Graham has been appointed the next CEO of Picomole Inc. Dr Graham will bring a wealth of knowledge to Picomole, as well strong leadership skills to lead the team in the future. Welcome Dr. Graham!